Accession Number: | 0001138639-21-000065 |
Date: | 2021-03-16 |
Issuer: | INFINERA CORP (INFN) |
Original Submission Date: |
WELCH DAVID F
C/O INFINERA CORPORATION
6373 SAN IGNACIO AVENUE
SAN JOSE, CA 95119
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-16 | S | 80,622 | d | $10.15 | 607,312 | indirect | f3 | |
COMMON STOCK | 2021-03-16 | 0 | $0.00 | 2,500 | indirect | f4 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | this sale was effected pursuant to dr. welch's rule 10b5-1 trading plan, which was adopted on november 20, 2019. |
f2 | this price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $10.00 to $10.25 per share. upon request by the staff of the securities and exchange commission, infinera corporation (the "company") or a security holder of the company, dr. welch will provide full information regarding the number of shares sold at each separate price. |
f3 | these shares are held directly by the welch family trust u/a dtd 4/3/1996 ("the welch family trust"), for which dr. welch is a trustee. |
f4 | these shares are held directly by dr. welch as a trustee for his children. dr. welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that dr. welch is the beneficial owner of the shares held in trust for his children for purposes of section 16 or for any other purpose. |